NXP Semiconductors NV forecast fourth-quarter revenue below estimates on Monday, as it anticipates uncertain demand and broader macroeconomic weakness in Europe and the...
Boston-based Bicara Therapeutics became a public company on Wednesday by listing on Nasdaq. Claire Mazumdar, chief executive of Bicara, said the company now...
